LIVERVELL

This brand name is authorized in Turkey

Active ingredients

The drug LIVERVELL contains one active pharmaceutical ingredient (API):

1 2,5-Diaminopentanoate
UNII JA08T3B97O - ORNITHINE ASPARTATE
Read about 2,5-Diaminopentanoate

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
A05BA Liver therapy A Alimentary tract and metabolism → A05 Bile and liver therapy → A05B Liver therapy, lipotropics
Discover more medicines within A05BA

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: TR ฤฐlaรง ve Tฤฑbbi Cihaz Kurumu Identifier(s): 8699651761181

ยฉ All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈